Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Phase 3 validation of early detection biomarker panel for pancreatic cancer

Datasets


Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • No history of any cancer before trial and rare cancer during trial (Controls)
  • UCLA Serum and EDTA Plasma Available
  • Pre-Dx UCLA Serum and EDTA Plasma Available

Matching Factors:

  • Gender
  • Age level
  • Race
  • Study Year of Blood Draw
  • Date of Draw (+/- 365 days)

Match Ratio: 2:1

Match Technique: Individual matching without replacement only cases as controls.


Analytes:

  • Cancer Antigen 19-9
  • Thrombospondin-2

Number of Cases: 238

Number of Controls: 476